well

Stop Wasting AI on Personal Productivity: 60% of Leaders Pivot to Agentic Automation for Real Enterprise Value

New Research Confirms Costly Copilot Limitations, Driving Demand for Governed, Process-Centric AI Solutions That Accelerate Autonomy SAN JOSE, Calif., June…

2 weeks ago

PIF launches new company to deliver Expo 2030 Riyadh

Expo 2030 Riyadh Company will develop Expo as a model for sustainable tourism, and preserve the event's legacyExpo 2030 Riyadh…

2 weeks ago

Expro Wins Well Test Contract for Major UK CCS Project

Latest contract extends Expro’s decade-plus support of the UK Carbon Capture and Storage (CCS) industryABERDEEN, Scotland--(BUSINESS WIRE)--Energy services provider, Expro…

2 weeks ago

Interlace Launches White-Label Card Solutions to Power Personalized Enterprise Payments

SINGAPORE, June 16, 2025 /PRNewswire/ -- As digital transformation accelerates, enterprises are increasingly challenged by inefficient payment systems — ranging…

2 weeks ago

Desay Battery Unveils Innovative Energy Storage Solutions at SNEC PV+ Expo, Announces Strategic Partnership with Turkish Energy Leader Demir Enerji

HUIZHOU, China, June 12, 2025 /PRNewswire/ -- Desay Battery, a global leader in energy storage innovations, achieved a key milestone…

3 weeks ago

National Science Teaching Association Welcomes New Board and Leadership Council Members

MCLEAN, Va.--(BUSINESS WIRE)--#NSTA--The National Science Teaching Association (NSTA) today announced the newest members of its Board of Directors, as well…

3 weeks ago

Ellavoz Impact Capital Celebrates Cedar Creek Estates with Site Dedication in Jacksonville, Florida

Vertical Construction is Well UnderwayJACKSONVILLE, Fla.--(BUSINESS WIRE)--Ellavoz Impact Capital (EIC), a leading real estate impact investment and management firm, celebrated…

4 weeks ago

Kia Announces May 2025 Global Sales Results

May 2025 global sales of 269,148 units, up 1.7% Y/yOutside of Korea, Kia sold 223,817 units, up 2.6% Y/yKia SUVs…

1 month ago

Initial Data from the ARC-20 Study of Casdatifan Plus Cabozantinib Showed Nearly Half of Patients with Metastatic Kidney Cancer Had a Confirmed Response

Treatment with casdatifan, a HIF-2a inhibitor, plus cabozantinib, a tyrosine kinase inhibitor, showed a confirmed overall response rate (ORR) of…

1 month ago